1
The Effect of Fluvoxamine on Polysonogram in Depressed Patients With Insomnia
Condition(s):DepressionLast Updated:May 13, 2015Unknown status
Fluvoxamine as an Intervention: 86 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection
Condition(s):COVID 19; CoronavirusLast Updated:July 9, 2021Completed
3
Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)
Condition(s):Covid19; CoronavirusLast Updated:October 31, 2022Completed
4
Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia
Condition(s):COVID-19; Olfactory Disorder; ParosmiaLast Updated:March 11, 2022Withdrawn
5
A Clinical Trial of Fluvoxamine for Melancholia
Condition(s):Depressive Disorder; Endogenous Depression; MelancholiaLast Updated:April 12, 2022Recruiting
6
Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder
Condition(s):OCDLast Updated:July 15, 2021Recruiting
7
Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients
Condition(s):Covid19Last Updated:August 23, 2022Completed
8
Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients
Condition(s):SCHIZOPHRENIA 1 (Disorder)Last Updated:April 23, 2013Unknown status
9
Fluvoxamine for Adults With Mild to Moderate COVID-19
Condition(s):Severe Acute Respiratory Syndrome Coronavirus 2; Coronavirus Infection; Mild to Moderate COVID-19Last Updated:April 19, 2021Suspended
10
A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
Condition(s):Obsessive Compulsive DisorderLast Updated:December 4, 2017Completed